These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24651096)

  • 21. Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy.
    Breccia M; Stefania de Propris M; Molica M; Colafigli G; Minotti C; Diverio D; Latagliata R; Guarini A; Lo-Coco F; Foà R
    Am J Hematol; 2015 Sep; 90(9):E181-2. PubMed ID: 26119985
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of the STAT5B-RARA fusion transcript in acute promyelocytic leukemia with the normal chromosome 17 on G-banding.
    Kusakabe M; Suzukawa K; Nanmoku T; Obara N; Okoshi Y; Mukai HY; Hasegawa Y; Kojima H; Kawakami Y; Ninomiya H; Nagasawa T
    Eur J Haematol; 2008 May; 80(5):444-7. PubMed ID: 18221386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of BCR/ABL fusion gene in a patient with acute promyelocytic leukemia.
    Zhang LJ; Gan YM; Yu L
    Med Oncol; 2015 Jan; 32(1):382. PubMed ID: 25428388
    [No Abstract]   [Full Text] [Related]  

  • 24. Morphologic heterogeneity of acute promyelocytic leukemia: therapy-related acute promyelocytic leukemia presenting with FAB-M2 morphology.
    Sinha S; Aish L; Oo TH
    Am J Hematol; 2006 Jun; 81(6):475-6. PubMed ID: 16680741
    [No Abstract]   [Full Text] [Related]  

  • 25. Resistance to therapy in acute promyelocytic leukemia.
    Lehmann-Che J; Bally C; de Thé H
    N Engl J Med; 2014 Sep; 371(12):1170-2. PubMed ID: 25229938
    [No Abstract]   [Full Text] [Related]  

  • 26. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction].
    Lang L; Li HM; Liu H; Wang YM; Zhang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse models of acute promyelocytic leukemia.
    Pollock JL; Westervelt P; Walter MJ; Lane AA; Ley TJ
    Curr Opin Hematol; 2001 Jul; 8(4):206-11. PubMed ID: 11561157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics of acute promyelocytic leukemia with the STAT5B-RARA fusion gene.
    Zhang C; Wang Y; Liu B; Gong B; Gong X; Liu Y; Mi Y; Wang J
    Blood Cells Mol Dis; 2018 Mar; 69():71-73. PubMed ID: 29030091
    [No Abstract]   [Full Text] [Related]  

  • 29. Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia.
    Albano F; Zagaria A; Anelli L; Coccaro N; Tota G; Brunetti C; Minervini CF; Impera L; Minervini A; Cellamare A; Orsini P; Cumbo C; Casieri P; Specchia G
    Oncotarget; 2015 May; 6(15):13269-77. PubMed ID: 25944686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring PML-RARalpha in acute promyelocytic leukemia.
    Jurcic JG
    Curr Oncol Rep; 2003 Sep; 5(5):391-8. PubMed ID: 12895391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia.
    Turhan AG; Lemoine FM; Debert C; Bonnet ML; Baillou C; Picard F; Macintyre EA; Varet B
    Blood; 1995 Apr; 85(8):2154-61. PubMed ID: 7536493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PML/RAR alpha APL with undifferentiated morphology and stem cell immunophenotype.
    Foley R; Soamboonsrup P; Kouroukis T; Leber B; Carter RF; Sunisloe L; Chorneyko K; Neame PB
    Leukemia; 1998 Sep; 12(9):1492-3. PubMed ID: 9737702
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of a novel CPSF6-RARG fusion transcript in acute myeloid leukemia resembling acute promyelocytic leukemia.
    Qin YZ; Huang XJ; Zhu HH
    Leukemia; 2018 Oct; 32(10):2285-2287. PubMed ID: 29568099
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of a novel PML-RARG fusion in acute promyelocytic leukemia.
    Ha JS; Do YR; Ki CS; Lee C; Kim DH; Lee W; Ryoo NH; Jeon DS
    Leukemia; 2017 Sep; 31(9):1992-1995. PubMed ID: 28555082
    [No Abstract]   [Full Text] [Related]  

  • 35. Relapse of acute promyelocytic leukemia in the external auditory canal confirmed by PML/RARA dual-fusion and RARA break-apart fluorescence in situ hybridization.
    Minoda S; Akasaka T; Okanoue Y; Honjo G; Nakagawa M; Ohno H
    Ann Hematol; 2018 May; 97(5):909-911. PubMed ID: 29387977
    [No Abstract]   [Full Text] [Related]  

  • 36. Feasibility and clinical significance of real-time quantitative RT-PCR assay of PML-RARalpha fusion transcript in patients with acute promyelocytic leukemia.
    Gu BW; Hu J; Xu L; Yan H; Jin WR; Zhu YM; Zhao WL; Niu C; Cao Q; Su XY; Gu J; Ying HY; Chen Y; Xiong SM; Shen ZX; Chen Z; Chen SJ
    Hematol J; 2001; 2(5):330-40. PubMed ID: 11920269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute promyelocytic leukaemia with cryptic PML-RARA fusion.
    Wong KF; Chow E; Siu LL; Wong WS
    Br J Haematol; 2009 Apr; 145(1):2. PubMed ID: 19036120
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapy of molecular relapse in acute promyelocytic leukemia.
    Lo Coco F; Diverio D; Avvisati G; Petti MC; Meloni G; Pogliani EM; Biondi A; Rossi G; Carlo-Stella C; Selleri C; Martino B; Specchia G; Mandelli F
    Blood; 1999 Oct; 94(7):2225-9. PubMed ID: 10498592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy.
    Grimwade D; Jovanovic JV; Hills RK; Nugent EA; Patel Y; Flora R; Diverio D; Jones K; Aslett H; Batson E; Rennie K; Angell R; Clark RE; Solomon E; Lo-Coco F; Wheatley K; Burnett AK
    J Clin Oncol; 2009 Aug; 27(22):3650-8. PubMed ID: 19506161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-genome sequencing and acute promyelocytic leukemia.
    Lo-Coco F; Sanz MA
    JAMA; 2011 Aug; 306(6):610; author reply 610-1. PubMed ID: 21828321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.